{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:58:30Z","timestamp":1787317110443,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["UF1 AG032438"],"award-info":[{"award-number":["UF1 AG032438"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG046374"],"award-info":[{"award-number":["AG046374"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DIAN-TU Pharma Consortium"},{"name":"Yulgilbar Alzheimer\u2019s Research Program"},{"name":"DHB Foundation"},{"name":"National Health and Medical Research Council Practitioner Fellowship"},{"name":"Australian Research Council Future Fellowship","award":["FT140100047"],"award-info":[{"award-number":["FT140100047"]}]},{"name":"Operational Infrastructure Support from the Victorian Government"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13195-018-0400-0","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T14:01:52Z","timestamp":1532527312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network"],"prefix":"10.1186","volume":"10","author":[{"name":"the Dominantly Inherited Alzheimer Network (DIAN)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-5547","authenticated-orcid":false,"given":"Celeste M.","family":"Karch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dami\u00e1n","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Chyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex W.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Levitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Sigurdson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino","family":"Ghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Farlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeer","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"P\u00e9bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"400_CR1","first-page":"77sr71","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, Morris JC, Goate AM. Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med. 2011;3:77sr71.","journal-title":"Sci Transl Med"},{"key":"400_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","volume":"33","author":"RJ Guerreiro","year":"2012","unstructured":"Guerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer\u2019s disease: beyond APP, PSENs and APOE. Neurobiol Aging. 2012;33:437\u201356.","journal-title":"Neurobiol Aging"},{"key":"400_CR3","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283:29615\u20139.","journal-title":"J Biol Chem"},{"key":"400_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"400_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804.","journal-title":"N Engl J Med"},{"key":"400_CR6","doi-asserted-by":"publisher","first-page":"226ra230","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"AM Fagan","year":"2014","unstructured":"Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease. Sci Transl Med. 2014;6:226ra230.","journal-title":"Sci Transl Med"},{"key":"400_CR7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.22117","volume":"33","author":"M Cruts","year":"2012","unstructured":"Cruts M, Theuns J, Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat. 2012;33:1340\u20134.","journal-title":"Hum Mutat"},{"key":"400_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/mp.2017.218","volume":"23","author":"S Hunter","year":"2018","unstructured":"Hunter S, Brayne C. Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. Mol Psychiatry. 2018;23:81\u201393.","journal-title":"Mol Psychiatry"},{"key":"400_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ. Mutation of the \u03b2-amyloid precursor protein in familial Alzheimer\u2019s disease increases \u03b2-protein production. Nature. 1992;360:672\u20134.","journal-title":"Nature"},{"key":"400_CR10","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/00001756-200210280-00005","volume":"13","author":"C Stenh","year":"2002","unstructured":"Stenh C, Nilsberth C, Hammarback J, Engvall B, Naslund J, Lannfelt L. The Arctic mutation interferes with processing of the amyloid precursor protein. Neuroreport. 2002;13:1857\u201360.","journal-title":"Neuroreport"},{"key":"400_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C. Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3:1.","journal-title":"Alzheimers Res Ther"},{"key":"400_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","volume":"83","author":"CM Karch","year":"2014","unstructured":"Karch CM, Cruchaga C, Goate AM. Alzheimer\u2019s disease genetics: from the bench to the clinic. Neuron. 2014;83:11\u201326.","journal-title":"Neuron"},{"key":"400_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","volume":"31","author":"RJ Guerreiro","year":"2010","unstructured":"Guerreiro RJ, Baquero M, Blesa R, Boada M, Br\u00e1s JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, et al. Genetic screening of Alzheimer\u2019s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging. 2010;31:725\u201331.","journal-title":"Neurobiol Aging"},{"key":"400_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nm0296-224","volume":"2","author":"DM Kovacs","year":"1996","unstructured":"Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM, et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med. 1996;2:224\u20139.","journal-title":"Nat Med"},{"key":"400_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","volume":"38","author":"B De Strooper","year":"2003","unstructured":"De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active \u03b3-secretase complex. Neuron. 2003;38:9\u201312.","journal-title":"Neuron"},{"key":"400_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83:253\u201360.","journal-title":"Neurology"},{"key":"400_CR17","doi-asserted-by":"publisher","first-page":"e31039","DOI":"10.1371\/journal.pone.0031039","volume":"7","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PLoS One. 2012;7:e31039.","journal-title":"PLoS One"},{"key":"400_CR18","doi-asserted-by":"publisher","first-page":"e1003685","DOI":"10.1371\/journal.pgen.1003685","volume":"9","author":"BA Benitez","year":"2013","unstructured":"Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, Bertelsen S, Chibnik L, Schneider JA, Bennett DA, et al. The PSEN1, p.E318G variant increases the risk of Alzheimer\u2019s disease in APOE-\u03b54 carriers. PLoS Genet. 2013;9:e1003685.","journal-title":"PLoS Genet"},{"key":"400_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, et al. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Hum Mol Genet. 2004;13:159\u201370.","journal-title":"Hum Mol Genet"},{"key":"400_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"400_CR21","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Chavez-Gutierrez","year":"2012","unstructured":"Chavez-Gutierrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L, Van Cleynenbreugel S, Esselmann H, et al. The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease. EMBO J. 2012;31:2261\u201374.","journal-title":"EMBO J"},{"key":"400_CR22","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaneurol.2014.2482","volume":"71","author":"Q Liu","year":"2014","unstructured":"Liu Q, Waltz S, Woodruff G, Ouyang J, Israel MA, Herrera C, Sarsoza F, Tanzi RE, Koo EH, Ringman JM, et al. Effect of potent \u03b3-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers. JAMA Neurol. 2014;71:1481\u20139.","journal-title":"JAMA Neurol"},{"key":"400_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature. 2012;482:216\u201320.","journal-title":"Nature"},{"key":"400_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1126\/science.1158799","volume":"321","author":"JT Dimos","year":"2008","unstructured":"Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218\u201321.","journal-title":"Science"},{"key":"400_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","volume":"8","author":"HN Nguyen","year":"2011","unstructured":"Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee K, Schule B, Dolmetsch RE, Langston W, et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011;8:267\u201380.","journal-title":"Cell Stem Cell"},{"key":"400_CR26","doi-asserted-by":"publisher","first-page":"e13947","DOI":"10.1371\/journal.pone.0013947","volume":"5","author":"M Iovino","year":"2010","unstructured":"Iovino M, Patani R, Watts C, Chandran S, Spillantini MG. Human stem cell-derived neurons: a system to study human tau function and dysfunction. PLoS One. 2010;5:e13947.","journal-title":"PLoS One"},{"key":"400_CR27","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.15252\/emmm.201708191","volume":"9","author":"EW Hollingsworth","year":"2017","unstructured":"Hollingsworth EW, Vaughn JE, Orack JC, Skinner C, Khouri J, Lizarraga SB, Hester ME, Watanabe F, Kosik KS, Imitola J. iPhemap: an atlas of phenotype to genotype relationships of human iPSC models of neurological diseases. EMBO Mol Med. 2017;9:1742\u201362.","journal-title":"EMBO Mol Med"},{"key":"400_CR28","first-page":"124ra129","volume":"4","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Smith J, MacLean G, Orkin SH, Livesey FJ. A human stem cell model of early Alzheimer\u2019s disease pathology in Down syndrome. Sci Transl Med. 2012;4:124ra129.","journal-title":"Sci Transl Med"},{"key":"400_CR29","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","volume":"23","author":"CR Muratore","year":"2014","unstructured":"Muratore CR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LN, Walsh DM, Selkoe DJ, Young-Pearse TL. The familial Alzheimer\u2019s disease APPV717I mutation alters APP processing and tau expression in iPSC-derived neurons. Hum Mol Genet. 2014;23:3523\u201336.","journal-title":"Hum Mol Genet"},{"key":"400_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, Yeromin AV, Scarfone VM, Marsh SE, Fimbres C, et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron. 2017;94:278\u2013293.e9.","journal-title":"Neuron"},{"key":"400_CR31","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.stemcr.2017.06.018","volume":"9","author":"J TCW","year":"2017","unstructured":"TCW J, Wang M, Pimenova AA, Bowles KR, Hartley BJ, Lacin E, Machlovi SI, Abdelaal R, Karch CM, Phatnani H, et al. An efficient platform for astrocyte differentiation from human induced pluripotent stem cells. Stem Cell Reports. 2017;9:600\u201314.","journal-title":"Stem Cell Reports"},{"key":"400_CR32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.celrep.2013.10.018","volume":"5","author":"G Woodruff","year":"2013","unstructured":"Woodruff G, Young JE, Martinez FJ, Buen F, Gore A, Kinaga J, Li Z, Yuan SH, Zhang K, Goldstein LS. The presenilin-1 \u0394E9 mutation results in reduced \u03b3-secretase activity, but not total loss of PS1 function, in isogenic human stem cells. Cell Rep. 2013;5:974\u201385.","journal-title":"Cell Rep"},{"key":"400_CR33","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/nm.4189","volume":"22","author":"J Muffat","year":"2016","unstructured":"Muffat J, Li Y, Yuan B, Mitalipova M, Omer A, Corcoran S, Bakiasi G, Tsai LH, Aubourg P, Ransohoff RM, Jaenisch R. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat Med. 2016;22:1358\u201367.","journal-title":"Nat Med"},{"key":"400_CR34","doi-asserted-by":"publisher","first-page":"e0161969","DOI":"10.1371\/journal.pone.0161969","volume":"11","author":"WK Raja","year":"2016","unstructured":"Raja WK, Mungenast AE, Lin YT, Ko T, Abdurrob F, Seo J, Tsai LH. Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer\u2019s disease phenotypes. PLoS One. 2016;11:e0161969.","journal-title":"PLoS One"},{"key":"400_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"400_CR36","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1073\/pnas.1103509108","volume":"108","author":"H Ban","year":"2011","unstructured":"Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A. 2011;108:14234\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"400_CR37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.18632\/aging.101247","volume":"9","author":"DE Crombie","year":"2017","unstructured":"Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, Minami I, Evans-Galea MV, Lim SY, Delbridge L, et al. Friedreich\u2019s ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency. Aging (Albany NY). 2017;9:1440\u201352.","journal-title":"Aging (Albany NY)"},{"key":"400_CR38","doi-asserted-by":"publisher","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS One. 2012;7:e50976.","journal-title":"PLoS One"},{"key":"400_CR39","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17:1665\u201374.","journal-title":"Genome Res"},{"key":"400_CR40","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/nar\/gkm076","volume":"35","author":"S Colella","year":"2007","unstructured":"Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, Bassett AS, Seller A, Holmes CC, Ragoussis J. QuantiSNP: an objective Bayes hidden-Markov model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res. 2007;35:2013\u201325.","journal-title":"Nucleic Acids Res"},{"key":"400_CR41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, Bala S, Bensaddek D, Casale FP, Culley OJ, et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature. 2017;546:370\u20135.","journal-title":"Nature"},{"key":"400_CR42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.18632\/aging.101231","volume":"9","author":"RCB Wong","year":"2017","unstructured":"Wong RCB, Lim SY, Hung SSC, Jackson S, Khan S, Van Bergen NJ, De Smit E, Liang HH, Kearns LS, Clarke L, et al. Mitochondrial replacement in an iPSC model of Leber\u2019s hereditary optic neuropathy. Aging (Albany NY). 2017;9:1341\u201350.","journal-title":"Aging (Albany NY)"},{"key":"400_CR43","doi-asserted-by":"publisher","first-page":"189ra177","DOI":"10.1126\/scitranslmed.3005615","volume":"5","author":"R Potter","year":"2013","unstructured":"Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, et al. Increased in vivo amyloid-\u03b242 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med. 2013;5:189ra177.","journal-title":"Sci Transl Med"},{"key":"400_CR44","doi-asserted-by":"publisher","first-page":"e18648","DOI":"10.7554\/eLife.18648","volume":"5","author":"CJ Huh","year":"2016","unstructured":"Huh CJ, Zhang B, Victor MB, Dahiya S, Batista LF, Horvath S, Yoo AS. Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts. Elife. 2016;5:e18648.","journal-title":"Elife"},{"key":"400_CR45","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1172\/JCI63113","volume":"122","author":"LH Martens","year":"2012","unstructured":"Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, Min SW, Gan L, Finkbeiner S, Huang EJ, Farese RV Jr. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest. 2012;122:3955\u20139.","journal-title":"J Clin Invest"},{"key":"400_CR46","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349:704\u20136.","journal-title":"Nature"},{"key":"400_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38:24\u20136.","journal-title":"Nat Genet"},{"key":"400_CR48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/neup.12205","volume":"35","author":"NJ Cairns","year":"2015","unstructured":"Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer disease neuroimaging initiative (ADNI) and the dominantly inherited Alzheimer network (DIAN). Neuropathology. 2015;35:390\u2013400.","journal-title":"Neuropathology"},{"key":"400_CR49","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N. Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20:4530\u20139.","journal-title":"Hum Mol Genet"},{"key":"400_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-2012-120172","volume":"30","author":"D Wallon","year":"2012","unstructured":"Wallon D, Rousseau S, Rovelet-Lecrux A, Quillard-Muraine M, Guyant-Marechal L, Martinaud O, Pariente J, Puel M, Rollin-Sillaire A, Pasquier F, et al. The French series of autosomal dominant early onset Alzheimer\u2019s disease cases: mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis. 2012;30:847\u201356.","journal-title":"J Alzheimers Dis"},{"key":"400_CR51","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/brain\/awh179","volume":"127","author":"K Sleegers","year":"2004","unstructured":"Sleegers K, Roks G, Theuns J, Aulchenko YS, Rademakers R, Cruts M, van Gool WA, Van Broeckhoven C, Heutink P, Oostra BA, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain. 2004;127:1641\u20139.","journal-title":"Brain"},{"key":"400_CR52","doi-asserted-by":"publisher","first-page":"1850.e17","DOI":"10.1016\/j.neurobiolaging.2012.02.020","volume":"33","author":"E Lohmann","year":"2012","unstructured":"Lohmann E, Guerreiro RJ, Erginel-Unaltuna N, Gurunlian N, Bilgic B, Gurvit H, Hanagasi HA, Luu N, Emre M, Singleton A. Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiol Aging. 2012;33:1850.e17\u201327.","journal-title":"Neurobiol Aging"},{"key":"400_CR53","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archneur.60.11.1541","volume":"60","author":"A Tedde","year":"2003","unstructured":"Tedde A, Nacmias B, Ciantelli M, Forleo P, Cellini E, Bagnoli S, Piccini C, Caffarra P, Ghidoni E, Paganini M, et al. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease. Arch Neurol. 2003;60:1541\u20134.","journal-title":"Arch Neurol"},{"key":"400_CR54","doi-asserted-by":"publisher","first-page":"2881.e1","DOI":"10.1016\/j.neurobiolaging.2014.06.002","volume":"35","author":"C Sassi","year":"2014","unstructured":"Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, Al-Sarraj S, Niblock M, Gallo JM, Adnan J, et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:2881.e1\u20136.","journal-title":"Neurobiol Aging"},{"key":"400_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00415-006-0373-y","volume":"254","author":"C Tomaino","year":"2007","unstructured":"Tomaino C, Bernardi L, Anfossi M, Costanzo A, Ferrise F, Gallo M, Geracitano S, Maletta R, Curcio SA, Mirabelli M, et al. Presenilin 2 Ser130Leu mutation in a case of late-onset \u201csporadic\u201d Alzheimer\u2019s disease. J Neurol. 2007;254:391\u20133.","journal-title":"J Neurol"},{"key":"400_CR56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","volume":"92","author":"ES Walker","year":"2005","unstructured":"Walker ES, Martinez M, Brunkan AL, Goate A. Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in A\u03b2 42\/40 ratios. J Neurochem. 2005;92:294\u2013301.","journal-title":"J Neurochem"},{"key":"400_CR57","doi-asserted-by":"publisher","first-page":"975","DOI":"10.4155\/cli.12.93","volume":"2","author":"JC Morris","year":"2012","unstructured":"Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, et al. Developing an international network for Alzheimer research: the dominantly inherited Alzheimer network. Clin Investig (Lond). 2012;2:975\u201384.","journal-title":"Clin Investig (Lond)"},{"key":"400_CR58","doi-asserted-by":"publisher","first-page":"208.e11","DOI":"10.1016\/j.neurobiolaging.2015.09.016","volume":"37","author":"C Blauwendraat","year":"2016","unstructured":"Blauwendraat C, Wilke C, Jansen IE, Schulte C, Simon-Sanchez J, Metzger FG, Bender B, Gasser T, Maetzler W, Rizzu P, et al. Pilot whole-exome sequencing of a German early-onset Alzheimer\u2019s disease cohort reveals a substantial frequency of PSEN2 variants. Neurobiol Aging. 2016;37:208.e11\u20137.","journal-title":"Neurobiol Aging"},{"key":"400_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10048-005-0211-x","volume":"6","author":"U Finckh","year":"2005","unstructured":"Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A. Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics. 2005;6:85\u20139.","journal-title":"Neurogenetics"},{"key":"400_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archneur.57.6.885","volume":"57","author":"JR Murrell","year":"2000","unstructured":"Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B. Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol. 2000;57:885\u20137.","journal-title":"Arch Neurol"},{"key":"400_CR61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1212\/01.WNL.0000197791.53828.2C","volume":"66","author":"AK Godbolt","year":"2006","unstructured":"Godbolt AK, Beck JA, Collinge JC, Cipolotti L, Fox NC, Rossor MN. A second family with familial AD and the V717L APP mutation has a later age at onset. Neurology. 2006;66:611\u20132.","journal-title":"Neurology"},{"key":"400_CR62","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0b013e3182515972","volume":"78","author":"BV Hooli","year":"2012","unstructured":"Hooli BV, Mohapatra G, Mattheisen M, Parrado AR, Roehr JT, Shen Y, Gusella JF, Moir R, Saunders AJ, Lange C, et al. Role of common and rare APP DNA sequence variants in Alzheimer disease. Neurology. 2012;78:1250\u20137.","journal-title":"Neurology"},{"key":"400_CR63","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1212\/WNL.46.6.1721","volume":"46","author":"Y Matsumura","year":"1996","unstructured":"Matsumura Y, Kitamura E, Miyoshi K, Yamamoto Y, Furuyama J, Sugihara T. Japanese siblings with missense mutation (717Val \u2192 Ile) in amyloid precursor protein of early-onset Alzheimer\u2019s disease. Neurology. 1996;46:1721\u20133.","journal-title":"Neurology"},{"key":"400_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0304-3940(95)12046-7","volume":"199","author":"WS Brooks","year":"1995","unstructured":"Brooks WS, Martins RN, De Voecht J, Nicholson GA, Schofield PR, Kwok JB, Fisher C, Yeung LU, Van Broeckhoven C. A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer\u2019s disease. Neurosci Lett. 1995;199:183\u20136.","journal-title":"Neurosci Lett"},{"key":"400_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ana.410380120","volume":"38","author":"S Sorbi","year":"1995","unstructured":"Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer\u2019s disease. Ann Neurol. 1995;38:124\u20137.","journal-title":"Ann Neurol"},{"key":"400_CR66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1086\/302702","volume":"66","author":"U Finckh","year":"2000","unstructured":"Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, Binetti G, Alberici A, Hock C, Nitsch RM, Gal A. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet. 2000;66:110\u20137.","journal-title":"Am J Hum Genet"},{"key":"400_CR67","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1159\/000313541","volume":"29","author":"G Talarico","year":"2010","unstructured":"Talarico G, Piscopo P, Gasparini M, Salati E, Pignatelli M, Pietracupa S, Malvezzi-Campeggi L, Crestini A, Boschi S, Lenzi GL, et al. The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2010;29:484\u201390.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"400_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J","volume":"11","author":"M Cruts","year":"1998","unstructured":"Cruts M, Van Broeckhoven C. Presenilin mutations in Alzheimer\u2019s disease. Hum Mutat. 1998;11:183\u201390.","journal-title":"Hum Mutat"},{"key":"400_CR69","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/jnnp.2006.113803","volume":"78","author":"KL Brickell","year":"2007","unstructured":"Brickell KL, Leverenz JB, Steinbart EJ, Rumbaugh M, Schellenberg GD, Nochlin D, Lampe TH, Holm IE, Van Deerlin V, Yuan W, Bird TD. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2007;78:1050\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"400_CR70","doi-asserted-by":"publisher","unstructured":"Hsu S, Gordon BA, Hornbeck R, Norton JB, Levitch D, Louden A, Ziegemeier E, Laforce R Jr, Chhatwal J, Day GS, McDade E, Morris JC, Fagan AM, Benzinger TLS, Goate AM, Cruchaga C, Bateman RJ, Dominantly Inherited Alzheimer Network (DIAN), Karch CM. Discovery and validation of autosomal dominant Alzheimer's disease mutations. Alzheimers Res Ther. 2018;10(1):67. \n                    https:\/\/doi.org\/10.1186\/s13195-018-0392-9\n                    \n                  .","DOI":"10.1186\/s13195-018-0392-9"},{"key":"400_CR71","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10072-010-0233-5","volume":"31","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Kim HY, Ki CS, Kim SH. Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer\u2019s disease: clinical characteristics and genetic identification. Neurol Sci. 2010;31:781\u20133.","journal-title":"Neurol Sci"},{"key":"400_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.20366","volume":"57","author":"GM Halliday","year":"2005","unstructured":"Halliday GM, Song YJ, Lepar G, Brooks WS, Kwok JB, Kersaitis C, Gregory G, Shepherd CE, Rahimi F, Schofield PR, Kril JJ. Pick bodies in a family with presenilin-1 Alzheimer\u2019s disease. Ann Neurol. 2005;57:139\u201343.","journal-title":"Ann Neurol"},{"key":"400_CR73","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1399-0004.1998.tb02597.x","volume":"53","author":"L Morelli","year":"1998","unstructured":"Morelli L, Prat MI, Levy E, Mangone CA, Castano EM. Presenilin 1 Met146Leu variant due to an A\u2192T transversion in an early-onset familial Alzheimer\u2019s disease pedigree from Argentina. Clin Genet. 1998;53:469\u201373.","journal-title":"Clin Genet"},{"key":"400_CR74","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1212\/WNL.0b013e3181d52785","volume":"74","author":"AC Bruni","year":"2010","unstructured":"Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, et al. Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology. 2010;74:798\u2013806.","journal-title":"Neurology"},{"key":"400_CR75","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0014-4886(03)00384-4","volume":"184","author":"C Zekanowski","year":"2003","unstructured":"Zekanowski C, Styczynska M, Peplonska B, Gabryelewicz T, Religa D, Ilkowski J, Kijanowska-Haladyna B, Kotapka-Minc S, Mikkelsen S, Pfeffer A, et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer\u2019s disease in Poland. Exp Neurol. 2003;184:991\u20136.","journal-title":"Exp Neurol"},{"key":"400_CR76","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3233\/JAD-2010-1292","volume":"19","author":"E Gomez-Tortosa","year":"2010","unstructured":"Gomez-Tortosa E, Barquero S, Baron M, Gil-Neciga E, Castellanos F, Zurdo M, Manzano S, Munoz DG, Jimenez-Huete A, Rabano A, et al. Clinical-genetic correlations in familial Alzheimer\u2019s disease caused by presenilin 1 mutations. J Alzheimers Dis. 2010;19:873\u201384.","journal-title":"J Alzheimers Dis"},{"key":"400_CR77","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.0.CO;2-F","volume":"11","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj P, Sharma V, Anderson L, Nemens E, Alonso ME, Orr H, White J, Heston L, Bird TD, Schellenberg GD. Missense mutations in the chromosome 14 familial Alzheimer\u2019s disease presenilin 1 gene. Hum Mutat. 1998;11:216\u201321.","journal-title":"Hum Mutat"},{"key":"400_CR78","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1001\/jama.286.18.2257","volume":"286","author":"ES Athan","year":"2001","unstructured":"Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, Rondon H, Lantigua RA, Medrano M, Torres M, et al. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA. 2001;286:2257\u201363.","journal-title":"JAMA"},{"key":"400_CR79","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1212\/WNL.57.4.621","volume":"57","author":"EA Rogaeva","year":"2001","unstructured":"Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E, Rogaev EI, Frommelt P, Sadovnick AD, et al. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology. 2001;57:621\u20135.","journal-title":"Neurology"},{"key":"400_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neulet.2010.10.039","volume":"487","author":"JM Ringman","year":"2011","unstructured":"Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, Apostolova LG, Barrio JR, Small G, Silverman DH, et al. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer\u2019s disease due to a novel PSEN1 mutation. Neurosci Lett. 2011;487:287\u201392.","journal-title":"Neurosci Lett"},{"key":"400_CR81","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jmg.2005.033456","volume":"42","author":"G Raux","year":"2005","unstructured":"Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer\u2019s disease: an update. J Med Genet. 2005;42:793\u20135.","journal-title":"J Med Genet"},{"key":"400_CR82","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1212\/WNL.0b013e3181b163ba","volume":"73","author":"JB Norton","year":"2009","unstructured":"Norton JB, Cairns NJ, Chakraverty S, Wang J, Levitch D, Galvin JE, Goate A. Presenilin1 G217R mutation linked to Alzheimer disease with cotton wool plaques. Neurology. 2009;73:480\u20132.","journal-title":"Neurology"},{"key":"400_CR83","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/S0002-9440(10)64688-3","volume":"158","author":"DM Mann","year":"2001","unstructured":"Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Familial Alzheimer\u2019s Disease Pathology Study Group. Amyloid angiopathy and variability in amyloid \u03b2 deposition is determined by mutation position in presenilin-1-linked Alzheimer\u2019s disease. Am J Pathol. 2001;158:2165\u201375.","journal-title":"Am J Pathol"},{"key":"400_CR84","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10048-006-0053-1","volume":"7","author":"J Murrell","year":"2006","unstructured":"Murrell J, Ghetti B, Cochran E, Macias-Islas MA, Medina L, Varpetian A, Cummings JL, Mendez MF, Kawas C, Chui H, Ringman JM. The A431E mutation in PSEN1 causing familial Alzheimer\u2019s disease originating in Jalisco state, Mexico: an additional fifteen families. Neurogenetics. 2006;7:277\u20139.","journal-title":"Neurogenetics"},{"key":"400_CR85","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10048-006-0043-3","volume":"7","author":"P Yescas","year":"2006","unstructured":"Yescas P, Huertas-Vazquez A, Villarreal-Molina MT, Rasmussen A, Tusie-Luna MT, Lopez M, Canizales-Quinteros S, Alonso ME. Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer\u2019s disease in Mexican families. Neurogenetics. 2006;7:195\u2013200.","journal-title":"Neurogenetics"},{"key":"400_CR86","doi-asserted-by":"publisher","first-page":"1481.e7","DOI":"10.1016\/j.neurobiolaging.2011.12.007","volume":"33","author":"V Dobricic","year":"2012","unstructured":"Dobricic V, Stefanova E, Jankovic M, Gurunlian N, Novakovic I, Hardy J, Kostic V, Guerreiro R. Genetic testing in familial and young-onset Alzheimer\u2019s disease: mutation spectrum in a Serbian cohort. Neurobiol Aging. 2012;33:1481.e7\u201312.","journal-title":"Neurobiol Aging"},{"key":"400_CR87","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00415-011-6066-1","volume":"258","author":"P Piscopo","year":"2011","unstructured":"Piscopo P, Talarico G, Malvezzi-Campeggi L, Crestini A, Rivabene R, Gasparini M, Tosto G, Vanacore N, Lenzi GL, Bruno G, Confaloni A. Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer\u2019s disease case. J Neurol. 2011;258:2043\u20137.","journal-title":"J Neurol"},{"key":"400_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajmg.b.30087","volume":"132B","author":"EM Wijsman","year":"2005","unstructured":"Wijsman EM, Daw EW, Yu X, Steinbart EJ, Nochlin D, Bird TD, Schellenberg GD. APOE and other loci affect age-at-onset in Alzheimer\u2019s disease families with PS2 mutation. Am J Med Genet B Neuropsychiatr Genet. 2005;132B:14\u201320.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"400_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.410230106","volume":"23","author":"TD Bird","year":"1988","unstructured":"Bird TD, Lampe TH, Nemens EJ, Miner GW, Sumi SM, Schellenberg GD. Familial Alzheimer\u2019s disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol. 1988;23:25\u201331.","journal-title":"Ann Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0400-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-018-0400-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0400-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:31:58Z","timestamp":1589527918000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0400-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1186\/s13195-018-0400-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Washington University IRB reviewed the study protocol (IRB no. 201104178, 201306108). All subjects included in this study, or their proxies, gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AMG is a member of the scientific advisory board for Denali Therapeutics and serves on the Genetic Scientific Advisory Panel for Pfizer. RJB receives laboratory research funding from the National Institutes of Health, Alzheimer\u2019s Association, BrightFocus Foundation, Rainwater Foundation Tau Consortium, Association for Frontotemporal Degeneration, the Cure Alzheimer\u2019s Fund, and the Tau SILK Consortium (AbbVie, Biogen, and Eli Lilly and Co.). Funding for clinical trials not related to this research include the National Institutes of Health, Alzheimer\u2019s Association, Eli Lilly and Co., Hoffman-La Roche, Janssen, Avid Radiopharmaceuticals, GHR Foundation, and an anonymous foundation. RJB also receives research funding from the DIAN Pharma Consortium (AbbVie, Amgen, AstraZeneca, Biogen, Eisai, Eli Lilly and Co., Hoffman-La Roche, Janssen, Pfizer, and Sanofi). RJB has received honoraria from Janssen and Pfizer as a speaker and from Merck and Pfizer as an advisory board member. Washington University, RJB, and DH have equity ownership interests in C2N Diagnostics and receive royalty income based on technology (stable isotope labeling kinetics and blood plasma assay) licensed by Washington University to C2N Diagnostics. RJB receives income from C2N Diagnostics for serving on its scientific advisory board. Washington University, with RJB as coinventor, has submitted the U.S. nonprovisional patent application \u201cMethods for Measuring the Metabolism of CNS Derived Biomolecules In Vivo\u201d and a provisional patent application, \u201cPlasma Based Methods for Detecting CNS Amyloid Deposition.\u201d The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"69"}}